Combining ethics, artificial intelligence and health

Published on

9/10/2023

Amended on

3/4/2024

minute(s)

Artificial intelligence is revolutionizing healthcare, putting people at the heart of the debate. David Gruson, founder of Ethik-IA, analyzes current regulations. How can ethics, technology and healthcare be reconciled? Do innovative companies stand out? Are investors integrating ethics into their choices? Here's how.

Damien Hélène

This article has been automatically translated. Please excuse any inaccuracies or translation errors.

At a time when artificial intelligence is revolutionizing the healthcare sector, there's one factor that must be taken into account: the human factor. How can we reconcile ethics, new technologies and healthcare?

Where do we stand from a regulatory standpoint? Do any companies stand out from the crowd? Do investment funds take ethics into account?

David Gruson answered our questions. He is the founder ofEthik-IA, former advisor to the Prime Minister in charge of health, and former Director General of the CHU de La Réunion.

Portrait of David Gruson and text displaying "Special Feature #1".

Private Equity

30/7/2024

Private equity continues to outperform other asset classes, including listed markets (France Invest)

Private Equity

30/7/2024

Private equity continues to outperform other asset classes, including listed markets (France Invest)

Fund manager

10/9/2024

Odyssey 2024

Clario, the pioneer of decentralized clinical trial technologies, backed by two decades of innovation

Europe, North America

Technology, Healthcare, Services

Company

17/10/2024

Odyssey 2022

team.blue acquires Metricool and ushers in a new era of social network management

#Unicorn

Europe

Technology and Software

in the spotlight

Artificial Intelligence at the service of health

New technologies are revolutionizing the healthcare sector more than ever. Artificial intelligence is now positioned as a diagnostic tool for certain cancers and cardiovascular diseases; it can also speed up clinical trials, predict potential complications linked to medical treatments and provide invaluable assistance with fertility. The managers of Vintage Altaroc have positioned themselves in this resilient, high-growth sector, which, as you will discover, offers the benefits of personalized, predictive medicine.

articles

Discover

Private Equity

17/10/2023